OMERACT active Working Groups (n = 42).
| Disease |
| ANCA Vasculitis (Core Set) |
| Behçet Syndrome |
| Ankylosing Spondylitis — Reference Case |
| Connective Tissue Diseases — Interstitial Lung Disease |
| Fibromyalgia (Core Set) |
| Flares in Osteoarthritis |
| Flares in Rheumatoid Arthritis |
| Glucocorticoid Adverse Events |
| Gout |
| Hand Osteoarthritis |
| International Classification of Functioning, Disability and Health |
| Juvenile Inflammatory Arthritis Core Set |
| Large Vessel Vasculitis |
| Myositis |
| Osteoarthritis (Core Set) |
| Osteoporosis (Core Set) |
| Pain |
| Polymyalgia Rheumatica (PMR) |
| Psoriatic Arthritis |
| Remission in Rheumatoid Arthritis — Patient Perspective |
| Rheumatoid Arthritis (Core Set) |
| Shoulder Pain Outcome Measures |
| Systemic Lupus Erythematosus |
| Total Joint Replacement |
| Imaging and Biomarkers |
| Gout Biomarker Group |
| Magnetic Resonance Imaging in Arthritis |
| Juvenile Arthritis Magnetic Resonance Imaging |
| Soluble Biomarkers |
| Study grouP for x-trEme Computed Tomography in Rheumatoid Arthritis |
| Statistical Analysis of Radiographic Data in Rheumatoid Arthritis Clinical Trials |
| Synovial Tissues in Randomized Clinical Trials |
| Ultrasound |
| Methods |
| Adaptive Clinical Trial Design |
| Item Response Theory and Computerized Adaptive Testing |
| Consensus for Consensus |
| Contextual Factors |
| Critical Outcomes in Longitudinal Studies |
| Safety in Rheumatology Clinical Trials Working Group |
| Equity |
| Quality-adjusted Life-years |
| Rasch Model and Minimal Important Difference |
| Health Literacy |
| Medication Adherence |
| Instrumentation Across Diseases |
| Shared Decision Making |
| Stiffness |
| Worker Productivity |
OMERACT: Outcome Measures in Rheumatology; ANCA: antineutrophil cytoplasmic antibody.